Co-Administration of Novel Oral Polio Vaccine Type 2 and Bivalent Oral Polio Vaccine: Current Evidence, Challenges, and Implications for the Polio Eradication Endgame.

Bateyi Mustafa SH, Rodrigue TP, Raoul RZ, Dominique BB

Open source

DOI
10.2147/idr.s625567
Published
2026
Container
Infection and drug resistance
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/idr.s625567,
  title = {Co-Administration of Novel Oral Polio Vaccine Type 2 and Bivalent Oral Polio Vaccine: Current Evidence, Challenges, and Implications for the Polio Eradication Endgame.},
  author = {Bateyi Mustafa SH and Rodrigue TP and Raoul RZ and Dominique BB},
  year = {2026},
  journal = {Infection and drug resistance},
  doi = {10.2147/idr.s625567},
  url = {https://doi.org/10.2147/idr.s625567}
}

RIS

TY  - JOUR
TI  - Co-Administration of Novel Oral Polio Vaccine Type 2 and Bivalent Oral Polio Vaccine: Current Evidence, Challenges, and Implications for the Polio Eradication Endgame.
AU  - Bateyi Mustafa SH
AU  - Rodrigue TP
AU  - Raoul RZ
AU  - Dominique BB
PY  - 2026
JO  - Infection and drug resistance
DO  - 10.2147/idr.s625567
UR  - https://doi.org/10.2147/idr.s625567
ER  - 

APA

SH, B. M., TP, R., RZ, R., & BB, D. (2026). Co-Administration of Novel Oral Polio Vaccine Type 2 and Bivalent Oral Polio Vaccine: Current Evidence, Challenges, and Implications for the Polio Eradication Endgame.. Infection and drug resistance. https://doi.org/10.2147/idr.s625567

Source records